Live Blog: Arizona's Bioscience Roadmap
Welcome to the Flinn Foundation Bio Blog where you will receive the latest news throughout 2025 (and beyond) on the next iteration of Arizona’s Bioscience Roadmap.
The Roadmap is the nation’s longest-running, statewide bioscience strategic plan. Bookmark this page for regular updates on the biosciences in Arizona and the development of the new Roadmap coming this fall.
Live Blog: Arizona's Bioscience Roadmap
News and Updates
Flinn Foundation names leadership of Arizona’s statewide bioscience committee
February 27, 2024
Higher education executive Heather Carter, UArizona biomedical engineer Jennifer Barton to serve as chair, vice chair Heather Carter and Jennifer Barton, accomplished Arizona leaders in the biosciences, higher education, and public policy, have been named chair and vice chair of…
Arizona Bioscience News: UArizona leads NIH funding; SciTech Festival event; HonorHealth’s new therapy
February 22, 2024
UArizona researchers top others in the state with NIH funding / Phoenix Business Journal When it comes to funding from the National Institutes of Health for medical research, Arizona ranks 25th in the nation with $364 million in awards for the fiscal…
Arizona Bioscience News: Biodesign Institute at 20; TGen’s valley fever discovery; Virtual reality in health care
February 15, 2024
Tempe-based GT Medical Technologies Inc. raised $45 million in March to expand its technology to treat patients with operable brain tumors—one of the largest venture capital funding deals in Arizona in 2023.
Flinn Foundation adds two Phoenix business leaders to its board of directors
February 12, 2024
Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors. Camacho, an advocate for the biosciences, other innovation industries, and the arts has served…
Arizona Bioscience News: Nanotechnology at ASU; Barrow Brain and Spine; Verde Valley SciTech
February 08, 2024
Tempe-based GT Medical Technologies Inc. raised $45 million in March to expand its technology to treat patients with operable brain tumors—one of the largest venture capital funding deals in Arizona in 2023.
Arizona Bioscience News: ASU medical school; Venture Madness finalists; Moonshot rural pitch competition
February 01, 2024
Tempe-based GT Medical Technologies Inc. raised $45 million in March to expand its technology to treat patients with operable brain tumors—one of the largest venture capital funding deals in Arizona in 2023.
Arizona Bioscience News: TGen’s new cancer detection tool; Peerlogic raises $5.6M; New UArizona long COVID study
January 25, 2024
Tempe-based GT Medical Technologies Inc. raised $45 million in March to expand its technology to treat patients with operable brain tumors—one of the largest venture capital funding deals in Arizona in 2023.
